Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth A Scientific the
暂无分享,去创建一个
S. Daniels | B. McCrindle | J. Steinberger | S. Gidding | L. Hayman | S. Cook | M. Mietus-Snyder | S. Ferranti | Michele Mietus-Snyder | Samuel S. Gidding | Julia Steinberger | Laura L. Hayman | Stephen Cook | Stephen R. Daniels | B. W. McCrindle | Michele L. Mietus-Snyder
[1] Sarah Hummasti,et al. Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes , 2010, Circulation research.
[2] S. Gidding,et al. Changes in Circulating Satiety Hormones in Obese Children: A Randomized Controlled Physical Activity‐Based Intervention Study , 2010, Obesity.
[3] M. Steiner,et al. Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood , 2010, Pediatrics.
[4] A. Gabory,et al. Conference on ‘ Over-and undernutrition : challenges and approaches ’ Symposium 2 : Modern approaches to nutritional research challenges Nutritional developmental epigenomics : immediate and long-lasting effects , 2010 .
[5] N. Mauras,et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. , 2010, The Journal of clinical endocrinology and metabolism.
[6] A. Fitzpatrick,et al. Obesity, asthma, and oxidative stress. , 2010, Journal of applied physiology.
[7] Steven L Gortmaker,et al. Dynamics of obesity and chronic health conditions among children and youth. , 2010, JAMA.
[8] M. Pencina,et al. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[9] A. Chervonsky,et al. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. , 2010, The Journal of clinical investigation.
[10] Xiaomin Liu,et al. Comparison of the Effects of Simvastatin versus Atorvastatin on Oxidative Stress in Patients With Type 2 Diabetes Mellitus , 2010, Journal of cardiovascular pharmacology.
[11] M. Chiariello,et al. Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? , 2009, Current vascular pharmacology.
[12] V. Preedy,et al. National Health and Nutrition Examination Survey , 2010 .
[13] J. Dudenhausen,et al. Childhood obesity, other cardiovascular risk factors, and premature death. , 2010, The New England journal of medicine.
[14] M. Vasse,et al. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[15] Paul M Ridker,et al. Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.
[16] A. Barnato,et al. Obesity, inflammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] A. López-Bermejo,et al. High-molecular-weight adiponectin in children born small- or appropriate-for-gestational-age. , 2009, The Journal of pediatrics.
[18] S. Daniels,et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. , 2009, Hypertension.
[19] B. Ames,et al. Clinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemia. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] M. Singer,et al. A cross-sectional study of food group intake and C-reactive protein among children , 2009, Nutrition & metabolism.
[21] E. Ford,et al. Trends in the Prevalence of Low Risk Factor Burden for Cardiovascular Disease Among United States Adults , 2009, Circulation.
[22] B. Kahn,et al. Retinol-binding protein 4 (RBP4): a biomarker for subclinical atherosclerosis? , 2009, American journal of hypertension.
[23] T. Lehtimäki,et al. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study , 2009, Journal of internal medicine.
[24] R. Vasan,et al. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. , 2009, Atherosclerosis.
[25] R. Martos,et al. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. , 2009, Metabolism: clinical and experimental.
[26] J. Jerling,et al. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease , 2009, European Journal of Clinical Nutrition.
[27] P. Brophy,et al. Long‐term Exercise Training in Overweight Adolescents Improves Plasma Peptide YY and Resistin , 2009, Obesity.
[28] E. Sellers,et al. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus , 2009, Pediatric diabetes.
[29] F. Harrell,et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.
[30] S. Daniels,et al. American Heart Association Childhood Obesity Research Summit: executive summary. , 2009, Circulation.
[31] K. Cianflone,et al. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents , 2009, International Journal of Obesity.
[32] Steven R Smith,et al. Early-life origins of metabolic dysfunction: role of the adipocyte , 2009, Trends in Endocrinology & Metabolism.
[33] S. O’Rahilly,et al. Leptin: a pivotal regulator of human energy homeostasis. , 2009, The American journal of clinical nutrition.
[34] R. Kelishadi,et al. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. , 2009, Atherosclerosis.
[35] J. Steinberger,et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. , 2009, Journal of the American Dietetic Association.
[36] M. Boaz,et al. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? , 2009, International Journal of Obesity.
[37] Sridevi Devaraj,et al. The evolving role of C-reactive protein in atherothrombosis. , 2009, Clinical chemistry.
[38] V. Mericq,et al. Insulin Resistance Markers in Children , 2009, Hormone Research in Paediatrics.
[39] M. Manns,et al. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis , 2009, Clinical endocrinology.
[40] P. Poulsen,et al. Retinol-Binding Protein 4 in Twins , 2009, Diabetes.
[41] P. Schreiner,et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis , 2009 .
[42] S. Daniels,et al. AHA Scientific Statement Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents Recommendations for Standard Assessment for Clinical Research A Scientific Statement From the American Heart Association , 2009 .
[43] G. Moneta,et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .
[44] P. Balagopal,et al. RBP4: from retinol transporter to biomarker? , 2009, The Journal of pediatrics.
[45] J. Eickhoff,et al. Fitness Level and Body Composition are Associated with Inflammation in Non-obese Children , 2009, Journal of pediatric endocrinology & metabolism : JPEM.
[46] S. Daniels,et al. The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. , 2009, The Journal of pediatrics.
[47] J. Eickhoff,et al. School-based Exercise Improves Fitness, Body Composition, Insulin Sensitivity, and Markers of Inflammation in Non-Obese Children , 2009, Journal of pediatric endocrinology & metabolism : JPEM.
[48] S. Daniels,et al. Progress and Challenges in Metabolic Syndrome in Children and Adolescents , 2009 .
[49] P. Kern,et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. , 2008, The Journal of clinical endocrinology and metabolism.
[50] S. O’Rahilly,et al. Human Obesity: A Heritable Neurobehavioral Disorder That Is Highly Sensitive to Environmental Conditions , 2008, Diabetes.
[51] K. Sameshima,et al. Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[52] B. Metcalf,et al. Adiponectin in childhood. , 2008, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.
[53] C. Frampton,et al. Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study. , 2008, Clinical biochemistry.
[54] H. Antunes,et al. Serum leptin levels in overweight children and adolescents , 2008, British Journal of Nutrition.
[55] S. Mariotti,et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. , 2008, The Journal of clinical endocrinology and metabolism.
[56] N. Mauras,et al. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D‐dimer and fibrinolytic balance to physical activity‐based intervention in obese children , 2008, Journal of thrombosis and haemostasis : JTH.
[57] G. Frühbeck,et al. Serum Amyloid A concentration is increased in obese children and adolescents. , 2008, The Journal of pediatrics.
[58] S. Sookoian,et al. A Decreased Mitochondrial DNA Content Is Related to Insulin Resistance in Adolescents , 2008, Obesity.
[59] R. Krauss,et al. Lipid metabolism in children and adolescents: Impact on vascular biology. , 2008, Journal of clinical lipidology.
[60] D. Mozaffarian,et al. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.
[61] J. Harrell,et al. Vigorous physical activity and cytokines in adolescents , 2008, European Journal of Applied Physiology.
[62] T. Reinehr,et al. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. , 2008, The Journal of clinical endocrinology and metabolism.
[63] H. Chung,et al. Molecular mechanism of PPAR in the regulation of age-related inflammation , 2008, Ageing Research Reviews.
[64] Mark M. Melendez,et al. Influence of Age on the Association of Retinol‐binding Protein 4 With Metabolic Syndrome , 2008, Obesity.
[65] B. Kahn,et al. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. , 2008, American journal of physiology. Endocrinology and metabolism.
[66] L. Heilbronn,et al. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. , 2008, Current pharmaceutical design.
[67] L. Bressollette. D-Dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. , 2008 .
[68] S. Gidding,et al. Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study , 2008, Circulation.
[69] M. Marcovecchio,et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. , 2008, Atherosclerosis.
[70] SoJung Lee,et al. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. , 2008, The Journal of pediatrics.
[71] Liming Pei,et al. Nuclear receptors: Decoding metabolic disease , 2008, FEBS letters.
[72] P. Poulsen,et al. Retinol-binding protein 4 in twins – regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action , 2008 .
[73] R. Kelishadi,et al. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. , 2008, Clinical chemistry.
[74] E. V. van Beek,et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. , 2007, The Journal of clinical endocrinology and metabolism.
[75] M. Ridderstråle,et al. Regulation of skeletal muscle PPARδ mRNA expression in twins , 2007, The Journal of physiology.
[76] R. Lehmann,et al. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. , 2007, The Journal of clinical endocrinology and metabolism.
[77] N. Tajima,et al. Ratio of high-, medium-, and low-molecular weight serum adiponectin to the total adiponectin value in children. , 2007, The Journal of pediatrics.
[78] T. Jones,et al. Exercise alone reduces insulin resistance in obese children independently of changes in body composition. , 2007, The Journal of clinical endocrinology and metabolism.
[79] P. Rabinovitch,et al. Transcriptional response to aging and caloric restriction in heart and adipose tissue , 2007, Aging cell.
[80] B. Balkau,et al. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. , 2007, Diabetes care.
[81] Margaret F. Gregor,et al. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.
[82] B. Bjelakovic,et al. Orexitropic Signaling Proteins in Obese Children , 2007, TheScientificWorldJournal.
[83] J. Manson,et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. , 2007, Archives of internal medicine.
[84] S. Brichard,et al. Determinants of early atherosclerosis in obese children and adolescents. , 2007, The Journal of clinical endocrinology and metabolism.
[85] P. Lepper,et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease , 2007, Diabetologia.
[86] Bounleut Phanavanh,et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. , 2007, The Journal of clinical endocrinology and metabolism.
[87] J. Steinberger,et al. In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children. , 2007, Metabolism: clinical and experimental.
[88] W. Cheung,et al. Adipokines and Gut Hormones in End-Stage Renal Disease , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[89] M. Poggi,et al. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance , 2007, Current opinion in lipidology.
[90] J. Auwerx,et al. Transcriptional coregulators in the control of energy homeostasis. , 2007, Trends in cell biology.
[91] T. Ekström,et al. Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? , 2007, Journal of internal medicine.
[92] V. Funanage,et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. , 2007, The Journal of clinical endocrinology and metabolism.
[93] J. Frystyk,et al. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. , 2007, The Journal of clinical endocrinology and metabolism.
[94] Jaimie N. Davis,et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. , 2007, The Journal of clinical endocrinology and metabolism.
[95] M. Matsuda,et al. Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.
[96] K. Kleinman,et al. Gestational weight gain and child adiposity at age 3 years. , 2007, American journal of obstetrics and gynecology.
[97] Ji-Won Lee,et al. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. , 2007, Metabolism: clinical and experimental.
[98] K. Park,et al. Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes , 2007, Diabetes Care.
[99] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[100] S. Barr,et al. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. , 2007, The Journal of clinical endocrinology and metabolism.
[101] N. Paynter,et al. The effect of weight loss on C-reactive protein: a systematic review. , 2007, Archives of internal medicine.
[102] W. James,et al. Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. , 2005, Journal of the American Academy of Dermatology.
[103] H. Yamanaka-Okumura,et al. Gene expression in low glycemic index diet - impact on metabolic control. , 2007, Forum of nutrition.
[104] D. Corella,et al. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance. , 2007, Clinical hemorheology and microcirculation.
[105] T. Omi,et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia , 2007, Human Genetics.
[106] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[107] A. Shirahata,et al. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. , 2006, The Journal of clinical endocrinology and metabolism.
[108] X. Papademetris,et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. , 2006, The Journal of clinical endocrinology and metabolism.
[109] S. Caprio,et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[110] M. Wolzt,et al. A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[111] L. Molinari,et al. Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. , 2006, The American journal of clinical nutrition.
[112] Jeffrey B. Schwimmer,et al. Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.
[113] Jaewon Oh. Retinol-binding protein 4 and insulin resistance. , 2006, The New England journal of medicine.
[114] M. Naito,et al. Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults. , 2006, Journal of atherosclerosis and thrombosis.
[115] Juan P Casas,et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. , 2006, International journal of epidemiology.
[116] P. Ciampalini,et al. NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice , 2006, Hepatology.
[117] J. Viikari,et al. Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[118] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[119] K. Gauvreau,et al. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. , 2006, Clinical chemistry.
[120] J. Steinberger,et al. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. , 2006, Journal of the cardiometabolic syndrome.
[121] R. Vasan,et al. Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.
[122] E. Rimm,et al. Adiponectin: a promising marker for cardiovascular disease. , 2006, Clinical chemistry.
[123] Ralph B D'Agostino,et al. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.
[124] B. Zinman,et al. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. , 2006, The Journal of pediatrics.
[125] T. Reinehr,et al. Resistin concentrations before and after weight loss in obese children , 2006, International Journal of Obesity.
[126] M. Fishbein,et al. Relationship of Hepatic Steatosis to Adipose Tissue Distribution in Pediatric Nonalcoholic Fatty Liver Disease , 2006, Journal of pediatric gastroenterology and nutrition.
[127] 池崎 綾子. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents , 2006 .
[128] J. Kirwan,et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. , 2006, Journal of Clinical Endocrinology and Metabolism.
[129] J. Stamler. Causes and mechanisms: an interview with Jeremiah Stamler. , 2006, Epidemiology.
[130] G. Creatsas,et al. Low-Grade Systemic Inflammation Profile, Unrelated to Homocysteinemia, in Obese Children , 2005, Mediators of inflammation.
[131] B. Rothermel,et al. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. , 2005, Diabetes.
[132] H. Yarandi,et al. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. , 2005, The Journal of clinical endocrinology and metabolism.
[133] S. Haffner,et al. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. , 2005, Diabetes.
[134] S. Baek,et al. Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties , 2005, Yonsei medical journal.
[135] H Tunstall-Pedoe,et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.
[136] T. Reinehr,et al. Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children , 2005, International Journal of Obesity.
[137] J. Molleston. The histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.
[138] T. Reinehr,et al. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. , 2005, Metabolism: clinical and experimental.
[139] M. Urban,et al. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. , 2005, Metabolism: clinical and experimental.
[140] D. Vaughan. PAI‐1 and atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[141] H. Scharnagl,et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. , 2005, The Journal of clinical endocrinology and metabolism.
[142] Nimesh Mody,et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.
[143] L. Hayman,et al. Inflammation, Insulin, and Endothelial Function in Overweight Children and Adolescents: The Role of Exercise , 2005 .
[144] J. Pankow,et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. , 2005, Diabetes care.
[145] J. Manson,et al. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. , 2005, Diabetes care.
[146] A. Syrenicz,et al. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. , 2005, Neuro endocrinology letters.
[147] J. Strong,et al. Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[148] A. Aviv,et al. Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition , 2005, Circulation.
[149] S. Arslanian,et al. Ghrelin suppression in overweight children: a manifestation of insulin resistance? , 2005, The Journal of clinical endocrinology and metabolism.
[150] R. Deutsch,et al. Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents , 2005, Pediatrics.
[151] D. Jacobs,et al. Relation of Body Mass Index and Insulin Resistance to Cardiovascular Risk Factors, Inflammatory Factors, and Oxidative Stress During Adolescence , 2005, Circulation.
[152] A. Mokdad,et al. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. , 2005, Diabetes care.
[153] S. Gidding,et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. , 2005, The Journal of pediatrics.
[154] Anand Rohatgi,et al. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans , 2005, Circulation.
[155] Gerald S. Berenson,et al. The Relation of Childhood BMI to Adult Adiposity: The Bogalusa Heart Study , 2005, Pediatrics.
[156] C. Lewis,et al. The CARDIA Study , 2009 .
[157] Philippe Giral,et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.
[158] A. Cheung,et al. Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. , 2004, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[159] B. Zinman,et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes.
[160] R. Marfella,et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. , 2004, JAMA.
[161] B. Kahn,et al. Peripheral signals set the tone for central regulation of metabolism. , 2004, Endocrinology.
[162] T. Reinehr,et al. Adiponectin before and after weight loss in obese children. , 2004, The Journal of clinical endocrinology and metabolism.
[163] A. LaCroix,et al. Tissue Plasminogen Activator Antigen and D-Dimer as Markers for Atherothrombotic Risk Among Healthy Postmenopausal Women , 2004, Circulation.
[164] A. Slyper. Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. , 2004, The Journal of clinical endocrinology and metabolism.
[165] P. Ridker,et al. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. , 2004, Circulation.
[166] Y. Asmann,et al. Proteomic research: potential opportunities for clinical and physiological investigators. , 2004, American journal of physiology. Endocrinology and metabolism.
[167] N. Wacher,et al. Low adiponectin levels predict type 2 diabetes in Mexican children. , 2004, Diabetes care.
[168] W. Hanif,et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. , 2004, Metabolism: clinical and experimental.
[169] C. Lamendola,et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. , 2004, Diabetes.
[170] S. Visvikis,et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. , 2004, Atherosclerosis.
[171] N. Gungor,et al. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. , 2004, Diabetes care.
[172] P. Whelton,et al. The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease , 2004, Annals of Internal Medicine.
[173] M. Alessi,et al. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis , 1991, Diabetologia.
[174] G. Palareti,et al. Haemorheologic and fibrinolytic evaluation in obese children and adolescents , 1988, European Journal of Pediatrics.
[175] C. Saha,et al. Lower serum adiponectin levels in African-American boys. , 2003, Obesity research.
[176] R. Pate,et al. Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1). , 2003, Medicine and science in sports and exercise.
[177] A. Dyer,et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. , 2003, JAMA.
[178] A. Shirahata,et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.
[179] C. Mantzoros,et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. , 2003, Obesity research.
[180] A. Mokdad,et al. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. , 2003, Diabetes.
[181] T. Shoji,et al. Decreased plasma adiponectin levels in young obese males. , 2003, Journal of atherosclerosis and thrombosis.
[182] O. Wagner,et al. D-dimer levels and risk of recurrent venous thromboembolism. , 2003, JAMA.
[183] T. Saruta,et al. Correlation between serum resistin level and adiposity in obese individuals. , 2003, Obesity research.
[184] B. Hedblad,et al. Inflammation-sensitive plasma proteins are associated with future weight gain. , 2003, Diabetes.
[185] Philip A Kern,et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. , 2003, Diabetes.
[186] J. Fernández-Real,et al. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. , 2003, The Journal of clinical endocrinology and metabolism.
[187] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[188] K. Cianflone,et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.
[189] T. Ogihara,et al. Role of endothelin-1 induced by insulin in the regulation of vascular cell growth. , 2003, American journal of hypertension.
[190] A. Folsom,et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.
[191] NoriyukiOuchi,et al. Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue , 2003 .
[192] C. Bereczki,et al. Oxidative stress in juvenile essential hypertension , 2003, Journal of hypertension.
[193] A. Massoud,et al. Circulating ICAM‐1, VCAM‐1, E‐Selectin, P‐Selectin, and TNFαRII in Patients with Coronary Artery Disease , 2003, Immunological investigations.
[194] S. O’Rahilly,et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[195] R. Martos,et al. Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children , 2003, International Journal of Obesity.
[196] Joseph L Evans,et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.
[197] N. Vaziri,et al. Effect of Diet and Exercise Intervention on Blood Pressure, Insulin, Oxidative Stress, and Nitric Oxide Availability , 2002, Circulation.
[198] T. Funahashi,et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. , 2002, The Journal of clinical endocrinology and metabolism.
[199] D. Nemet,et al. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. , 2002, Pediatrics.
[200] M. Litaker,et al. Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. , 2002, The Journal of pediatrics.
[201] R. Ferrari,et al. Cellular thiols redox status: a switch for NF-kappaB activation during myocardial post-ischaemic reperfusion. , 2002, Journal of molecular and cellular cardiology.
[202] T. Lehtimäki,et al. Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[203] A. Marette. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings , 2002, Current opinion in clinical nutrition and metabolic care.
[204] A. W. Miller,et al. Enhanced Endothelin Activity Prevents Vasodilation to Insulin in Insulin Resistance , 2002, Hypertension.
[205] C. Bogardus,et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.
[206] N. Mauras,et al. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. , 2002, American journal of physiology. Endocrinology and metabolism.
[207] A. Aljada,et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. , 2002, The Journal of clinical endocrinology and metabolism.
[208] M. Matsuda,et al. Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. , 2002, American journal of physiology. Heart and circulatory physiology.
[209] K. U. Lee,et al. Oxidative stress markers in Korean subjects with insulin resistance syndrome. , 2001, Diabetes research and clinical practice.
[210] M. Borkenstein,et al. Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program , 2001, International Journal of Obesity.
[211] D. Cooper,et al. Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.
[212] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[213] Y. Pak,et al. Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. , 2001, Diabetes care.
[214] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[215] D. Galuska,et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, The Journal of pediatrics.
[216] D. Shih,et al. The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.
[217] D. Le Roith,et al. Recent advances in our understanding of insulin action and insulin resistance. , 2001, Diabetes care.
[218] M. Goran. Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. , 2001, The American journal of clinical nutrition.
[219] P. Ridker,et al. Soluble P-Selectin and the Risk of Future Cardiovascular Events , 2001, Circulation.
[220] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[221] W. Koenig,et al. Exercise and thrombosis. , 2000, Cardiology clinics.
[222] D. Vaughan. Plasminogen Activator Inhibitor-1 and Vascular Disease in Diabetes Mellitus , 2001 .
[223] W. Muntean,et al. The Influence of Weight Loss on Fibrinolytic and Metabolic Parameters in Obese Children and Adolescents , 2001, Journal of pediatric endocrinology & metabolism : JPEM.
[224] A. Aljada,et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? , 2001, The Journal of clinical endocrinology and metabolism.
[225] M. Visser,et al. Low-grade systemic inflammation in overweight children. , 2001, Pediatrics.
[226] A. J. Bourne,et al. Non‐alcoholic steatohepatitis in children and adolescents , 2000, The Medical journal of Australia.
[227] W. Muntean,et al. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents , 2000, International Journal of Obesity.
[228] R. D'Agostino,et al. Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population , 2000, Circulation.
[229] S. Shea,et al. Inverse association of physical fitness with plasma fibrinogen level in children: the Columbia University BioMarkers Study. , 2000, American journal of epidemiology.
[230] A. Ahlbom,et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[231] A. Folsom,et al. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities. , 2000, Obesity research.
[232] K. Feingold,et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.
[233] B. Sobel,et al. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. , 2000, Diabetes.
[234] P. Morange,et al. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[235] D. Strachan,et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. , 2000, Atherosclerosis.
[236] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[237] A. Prentice,et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.
[238] W. Dietz,et al. The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study , 1999, Pediatrics.
[239] B. Sobel. Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. , 1999, Circulation.
[240] M. Litaker,et al. Effects of physical training and its cessation on the hemostatic system of obese children. , 1999, The American journal of clinical nutrition.
[241] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[242] M. Litaker,et al. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. , 1999, The American journal of clinical nutrition.
[243] A. Sharrett,et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[244] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[245] J. Sowers,et al. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. , 1998, Endocrinology.
[246] A. Rudich,et al. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. , 1998, Diabetes.
[247] S. O’Rahilly,et al. Depot-related gene expression in human subcutaneous and omental adipocytes. , 1998, Diabetes.
[248] P. Balagopal. In-vivo measurement of protein synthesis in humans. , 1998, Current opinion in clinical nutrition and metabolic care.
[249] L. Ragolia,et al. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. , 1998, The American journal of physiology.
[250] M. Litaker,et al. Fat distribution and hemostatic measures in obese children. , 1998, The American journal of clinical nutrition.
[251] R Peto,et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.
[252] J. Pankow,et al. Fibrinogen, Plasminogen Activator Inhibitor-1, and Carotid Intima-Media Wall Thickness in the NHLBI Family Heart Study , 1998, Thrombosis and Haemostasis.
[253] P. Ridker,et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.
[254] F. Emmrich,et al. Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children , 1998, Clinical Diagnostic Laboratory Immunology.
[255] K. Nair,et al. Age effect on fibrinogen and albumin synthesis in humans. , 1998, The American journal of physiology.
[256] E. Boerwinkle,et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.
[257] D. Strachan,et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. , 1997, Heart.
[258] W. Chandler,et al. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. , 1997, Circulation.
[259] M. Pfeffer,et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. , 1997, Circulation.
[260] S. Srinivasan,et al. Precursors of Cardiovascular Risk in Young Adults from a Biracial (Black–White) Population: The Bogalusa Heart Study , 1997, Annals of the New York Academy of Sciences.
[261] L. Breimer,et al. Fibrinogen as a cardiovascular risk factor. , 1997, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[262] E. E. Wein,et al. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Nutrition.
[263] M. El-sayed,et al. Effects of Exercise on Blood Coagulation, Fibrinolysis and Platelet Aggregation , 1996, Sports medicine.
[264] D. Brunner,et al. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[265] C. Christiansen,et al. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[266] J. Deanfield,et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[267] S. Corrao,et al. Hemostatic function in young subjects with central obesity: relationship with left ventricular function. , 1995, Metabolism: clinical and experimental.
[268] V. Salomaa,et al. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1995, Circulation.
[269] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[270] P. Ridker,et al. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.
[271] J. Vind,et al. The impact of static work on fibrinolysis and platelet function. , 1993, Thrombosis research.
[272] T. Meade,et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.
[273] T. Lakka,et al. Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. , 1993, Journal of clinical epidemiology.
[274] E. Horton,et al. Exercise training increases GLUT-4 protein in rat adipose cells. , 1993, The American journal of physiology.
[275] S. Srinivasan,et al. Plasma Fibrinogen and Its Correlates in Children from a Biracial Community: The Bogalusa Heart Study , 1993, Pediatric Research.
[276] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[277] M. Allan,et al. Retinoids and retinoid-binding protein expression in rat adipocytes. , 1992, The Journal of biological chemistry.
[278] J. Shafer,et al. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III. , 1991, The Journal of biological chemistry.
[279] M. Cerqueira,et al. Effects of Physical Conditioning on Fibrinolytic Variables and Fibrinogen in Young and Old Healthy Adults , 1991, Circulation.
[280] J. Norton,et al. Reversal of the toxic effects of cachectin by concurrent insulin administration. , 1989, The American journal of physiology.
[281] T. Patterson,et al. Relation of cardiovascular fitness and physical activity to cardiovascular disease risk factors in children and adults. , 1988, American journal of epidemiology.
[282] P. Mombaerts,et al. Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis , 1987, Thrombosis and Haemostasis.
[283] D. Goodman. PLASMA RETINOL‐BINDING PROTEIN * , 1980, Annals of the New York Academy of Sciences.
[284] D. J. Millward,et al. Protein turnover in mammalian tissues and in the whole body , 1978 .
[285] D. Goodman,et al. Retinol-binding protein: the transport protein for vitamin A in human plasma. , 1968, The Journal of clinical investigation.
[286] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.